The American Medical Association is urging doctors to use prescription drug monitoring programs to combat opioid abuse. The AMA Task Force to Reduce Opioid Abuse is urging health care providers to use staterun prescription drug monitoring programs to check a patient’s history when considering treatment options, the Chicagobased group said in a statement on Wednesday.
“When PDMPs are fully funded, contain relevant clinical information and are available at the point of care, they have been shown to be an effective tool to help physicians identify patients who may be misusing opioids, and to implement treatment strategies including referral for those in need of further care,” according to the statement. Some states, including New York, Massachusetts and Tennessee, require health care providers to access databases before prescribing opioids. Pennsylvania and Missouri are the only two states without prescription drug monitoring programs (/article/20150723/NEWS08/
The guidance regarding prescription drug monitoring is the first of several national recommendations to address the growing opioid epidemic, according to the statement. “We are committed to working longterm on a multipronged, comprehensive public health approach to end opioid abuse in America,” AMA Chairelect Dr. Patrice A. Harris said in the statement.